Ivabradine in patients with acute ST-elevation myocardial infarction: a meta-analysis of randomized controlled trials

BACKGROUND: Elevated resting heart rate (HR) predicts poor outcomes in patients with coronary artery disease. Ivabradine has been recommended as a second-line anti-anginal agent in chronic coronary syndrome, while there are no clear indications for acute ST-elevation myocardial infarction (STEMI). R...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasmita, Bryan Richard, Xie, Siyuan, Liu, Gang, Zhu, Yuansong, Luo, Suxin, Huang, Bi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079792/
https://www.ncbi.nlm.nih.gov/pubmed/37024594
http://dx.doi.org/10.1186/s43044-023-00351-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079792/
https://www.ncbi.nlm.nih.gov/pubmed/37024594
http://dx.doi.org/10.1186/s43044-023-00351-8

Ejemplares similares